U.S. District Judge Matthew Kacsmaryk ruled that Missouri, Kansas and Idaho can move ahead with a lawsuit seeking to revamp prescribing and use of the drug. Kaczmaryk, of the Northern District of Texas, has a history of strong anti-abortion views, according to The Washington Post.

After the Supreme Court overturned Roe in 2022, anti-abortion advocates launched a barrage of litigation, including a federal suit in Texas aimed at mifepristone, one drug in a two-drug regimen used in medication abortions.

The federal judge who paved a path for abortion drug clearance to reach the Supreme Court has allowed red states to revive the legal battle against mifepristone. | U.S. District Judge Matthew Kacsmaryk ruled Thursday that Idaho,

Idaho, Kansas and Missouri want the federal Food and Drug Administration to prohibit telehealth prescriptions for mifepristone and require that it be used only in the first seven weeks of

Since the U.S. Supreme Court’s decision in 2022 to allow states to regulate abortion access, support for expanded access to abortion pills has significantly increased, including among those living in states with abortion bans,